Lunai Bioworks Inc Quick Ratio (LNAI) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Lunai Bioworks Inc   (NASDAQ: LNAI)

Lunai Bioworks Inc 's Quick Ratio

LNAI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Lunai Bioworks Inc 's Cash & cash equivalent grew by 541.78 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Lunai Bioworks Inc 's Quick Ratio to 0.16, Quick Ratio remained below Lunai Bioworks Inc average.

Within Major Pharmaceutical Preparations industry 415 other companies have achieved higher Quick Ratio than Lunai Bioworks Inc in third quarter 2026. While Quick Ratio total ranking in the third quarter 2026 has deteriorated compared to the prior quarter from 3003 to 3336.

Explain Quick Ratio?
How much Cash & cash equivalents LNAI´s has?
What are LNAI´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

LNAI Quick Ratio (Mar 31 2026)
Q3		 (Dec 31 2025)
Q2		 (Sep 30 2025)
Q1		 (Jun 30 2025)
Q4		 (Mar 31 2025)
Q3
Y / Y Current Liabilities Change -33.14 % -39.64 % -26.36 % -39.3 % 38.17 %
Y / Y Cash & cash equivalent Change 241.85 % 57.7 % 183.27 % -57.95 % 195.17 %
Quick Ratio MRQ 0.16 0.03 0.04 0.01 0.03
LNAI's Total Ranking # 3336 # 3003 # 3600 # 0 # 0
Seq. Current Liabilities Change 11.67 % 1.79 % -7.8 % -36.21 % 0.82 %
Seq. Cash & cash equivalent Change 541.78 % -21.31 % 574.01 % -89.96 % 196.06 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 416
Healthcare Sector # 817
Overall Market # 3336


Quick Ratio Statistics
High Average Low
18.78 3.03 0
(Mar 31 2018)   (Dec 31 2013)




Financial Statements
Lunai Bioworks Inc 's Current Liabilities $ 19 Millions Visit LNAI's Balance sheet
Lunai Bioworks Inc 's Cash & cash equivalent $ 3 Millions Visit LNAI's Balance sheet
Source of LNAI's Sales Visit LNAI's Sales by Geography


Cumulative Lunai Bioworks Inc 's Quick Ratio

LNAI's Quick Ratio for the trailling 12 Months

LNAI Quick Ratio

 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months		 (Mar 31 2025)
12 Months
Y / Y Current Liabilities TTM Growth -35.09 % -20.77 % 5.49 % 31.78 % 99.42 %
Y / Y Cash & cash equivalent TTM Growth 160.44 % 100.11 % 95.67 % 19.02 % -43.28 %
Quick Ratio TTM 0.06 0.03 0.02 0.02 0.02
Total Ranking TTM # 4122 # 2304 # 2511 # 0 # 0
Seq. Current Liabilities TTM Growth -11.73 % -12.22 % -6.14 % -10.75 % 7.75 %
Seq. Cash & cash equivalent TTM Growth 104.7 % 9.21 % 26.11 % -7.62 % 57.28 %

Quick ratio ranking by company, industry and sector >> Back to LNAI Financial Strength Comparisons >> Go to Compare LNAI Quick Ratio to its Competitors

On the trailing twelve months basis LNAI Cash & cash equivalent more than doubled by 241.85 % in Q3 2026 year on year, while Current Liabilities increased to $19 millions, this led to increase in in Lunai Bioworks Inc 's Quick Ratio to 0.06, Quick Ratio remained below LNAI average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 441 other companies have achieved higher Quick Ratio than Lunai Bioworks Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2025 from 2304 to 4122.

Explain Quick Ratio?
How much Cash & cash equivalents LNAI´s has?
What are LNAI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 442
Healthcare Sector # 911
Within the Market # 4122


trailing twelve months Quick Ratio Statistics
High Average Low
9.61 2.08 0.01
(Mar 31 2020)   (Dec 31 2024)




Companies with similar Quick Ratio in the quarter ending Mar 31 2026, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2026 MRQ Cash & cash equivalentMar 31 2026 MRQ Current Liabilities
Ainos Inc   0.45 $ 2.841  Millions$ 6.347  Millions
Organon and Co   0.45 $ 1,116.000  Millions$ 2,500.000  Millions
Aytu Biopharma Inc  0.45 $ 26.715  Millions$ 59.972  Millions
Eton Pharmaceuticals Inc   0.45 $ 19.661  Millions$ 44.179  Millions
Earth Science Tech Inc   0.39 $ 0.797  Millions$ 2.029  Millions
Pfizer Inc  0.38 $ 13,075.000  Millions$ 34,348.000  Millions
Jupiter Neurosciences Inc   0.35 $ 2.363  Millions$ 6.723  Millions
Elanco Animal Health Incorporated  0.34 $ 428.000  Millions$ 1,262.000  Millions
Rein Therapeutics Inc   0.33 $ 4.445  Millions$ 13.637  Millions
Cumberland Pharmaceuticals Inc   0.32 $ 11.007  Millions$ 34.488  Millions
Bioxcel Therapeutics Inc   0.31 $ 17.180  Millions$ 54.994  Millions
Cytodyn inc   0.31 $ 15.655  Millions$ 50.428  Millions
Aurinia Pharmaceuticals Inc   0.28 $ 40.749  Millions$ 143.634  Millions
Amneal Pharmaceuticals Inc   0.28 $ 201.830  Millions$ 728.049  Millions
Eli Lilly And Company  0.28 $ 5,282.000  Millions$ 19,087.000  Millions
Teva Pharmaceutical Industries Limited  0.28 $ 3,741.000  Millions$ 13,544.000  Millions
Nrx Pharmaceuticals Inc   0.27 $ 6.713  Millions$ 25.176  Millions
Viatris Inc   0.26 $ 1,804.200  Millions$ 6,810.300  Millions
Ensysce Biosciences Inc   0.26 $ 0.745  Millions$ 2.837  Millions
Akari Therapeutics Plc  0.25 $ 2.768  Millions$ 10.975  Millions
Abbvie Inc   0.22 $ 9,391.000  Millions$ 42,100.000  Millions
Merck and Co Inc   0.21 $ 5,702.000  Millions$ 26,945.000  Millions
Indivior Pharmaceuticals Inc   0.21 $ 175.000  Millions$ 850.000  Millions
Xencor Inc  0.19 $ 14.170  Millions$ 73.457  Millions
International Stem Cell Corporation  0.18 $ 0.933  Millions$ 5.049  Millions
Jaguar Health Inc   0.18 $ 7.278  Millions$ 40.686  Millions
Lunai Bioworks Inc   0.16 $ 3.155  Millions$ 19.283  Millions
Shuttle Pharmaceuticals Holdings Inc   0.13 $ 1.090  Millions$ 8.306  Millions
Propanc Biopharma Inc   0.13 $ 0.444  Millions$ 3.476  Millions
Polomar Health Services, Inc.  0.10 $ 0.097  Millions$ 0.924  Millions

Date modified: 2026-09-26T07:27:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.